BMT CTN Protocol 0201 -- A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors

Below are protocol-related doucments, which may be periodically updated.

• Protocol synopsis, version 8.0 dated September 15, 2006
• Protocol, version 8.0 dated September 15, 2006
• Protocol amendment (summary of changes from version 7.0 to 8.0)
• Informed consents, version 8.0 dated September 15, 2006
• Health Quality of Life (HQL)
• Patient Questionnaire
• Participating centers
• Educational Materials
• Participant Brochure
• Frequently Asked Questions
• Informational Flyer
• Key Personnel

  Protocol Chair:  Claudio Anasetti, MD (813-745-3243) claudio.anasetti@moffitt.org

  Protocol Officer:  Dennis Confer, MD (612-362-3425) dconfer@nmdp.org

  Protocol Coordinator: Cathy Gurgol (301-251-1161) cgurgol@emmes.com

  Medical Monitor: Chris Bredeson, MD (414-805-4626) bredeson@mcw.edu

The target accrual of 550 patients on this study was reached on September 3, 2009.  No additional participation applications will be accepted for this study.